EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Machine learning-based prediction of treatment response in comorbid hepatitis C patients receiving DAA therapy: a real-world study from Pakistan

Dur E Nishwa, Zeeshan Abbas, Seung Won Lee

Frontiers in Public Health · 2026

DOI: 10.3389/fpubh.2026.1783217 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Public Health, 2026. Verfasst von Dur E Nishwa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Precision Medicine, Sungkyunkwan University, School of Medicine, Suwon, Republic of Korea. Hauptthemen laut MEDLINE: Antiviral Agents, Machine Learning, Hepatitis C, Hepatitis C, Chronic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hepatitis C virus (HCV) infection remains highly prevalent in Pakistan, particularly among patients with multiple comorbid conditions. Despite the widespread availability of direct-acting antivirals (DAAs), practical machine learning approaches to predict sustained virological response (SVR) are still lacking in resource-limited settings.

Methods

This retrospective cohort study analyzed 221 comorbid HCV patients treated with Sofosbuvir + Daclatasvir ± Ribavirin combination therapy. Baseline demographic and laboratory parameters were preprocessed using standard scaling methods. The dataset was split into 70% training and 30% testing subsets, and class imbalance in the training set was addressed using SMOTE. Five machine learning models, logistic regression, decision tree, random forest, XGBoost, and SVM, were tuned using stratified five-fold cross-validation. Evaluation metrics, including accuracy, precision, recall, specificity, F1-score, and ROC-AUC, were used to assess test-set performance, and SHAP analysis was conducted for the top-performing model.

Results

Among the 221 patients, 162 (73%) achieved SVR. Random Forest and SVM demonstrated the best discriminatory performance, with Random Forest achieving the highest accuracy (0.73), precision (0.84), and F1-score (0.81), while SVM produced the highest recall (0.82) and ROC-AUC (0.76). ALT and AST consistently emerged as the strongest predictors associated with treatment failure.

Conclusion

These findings support the potential of ML-based decision tools using routine clinical data in high-burden, resource-limited settings to guide risk stratification, optimize monitoring intensity, and inform public health strategies for HCV control and elimination in Pakistan and highlight the need for broader validation across larger, multicenter cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsMachine LearningHepatitis CHepatitis C, ChronicHumansPakistanRetrospective StudiesFemalePyrrolidinesMalePredictive Learning ModelsRandom ForestImidazolesSustained Virologic ResponseCarbamatesMiddle AgedBoosting Machine Learning AlgorithmsComorbidityClassification AlgorithmsSofosbuvirValineDrug Therapy, CombinationRibavirinAdult

Stichwörter der Autor:innen

direct-acting antivirals (DAAs)hepatitis C virus (HCV)machine learningsustained virological response (SVR)treatment response

Substanzen

Antiviral AgentsPyrrolidinesImidazolesCarbamatesdaclatasvirSofosbuvirValineRibavirin

Autor:innen und Institutionen

  • Department of Precision Medicine, Sungkyunkwan University, School of Medicine, Suwon, Republic of Korea.
  • Department of Biomedical Engineering, College of IT Convergence, Gachon University, Seongnam, Republic of Korea.
  • Department of Artificial Intelligence, Sungkyunkwan University, Suwon, Republic of Korea.
  • Department of Metabiohealth, Sungkyunkwan University, Suwon, Republic of Korea.
  • Personalized Cancer Immunotherapy Research Center, Sungkyunkwan University, School of Medicine, Suwon, Republic of Korea.
  • Department of Family Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Zitieren

APA

Nishwa, D. E., Abbas, Z., & Lee, S. W. (2026). Machine learning-based prediction of treatment response in comorbid hepatitis C patients receiving DAA therapy: a real-world study from Pakistan. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2026.1783217

Vancouver

Nishwa DE, Abbas Z, Lee SW. Machine learning-based prediction of treatment response in comorbid hepatitis C patients receiving DAA therapy: a real-world study from Pakistan. Frontiers in Public Health. 2026. doi:10.3389/fpubh.2026.1783217

BibTeX
@article{Nishwa2026,
  author = {Nishwa, Dur E and Abbas, Zeeshan and Lee, Seung Won},
  title = {Machine learning-based prediction of treatment response in comorbid hepatitis C patients receiving DAA therapy: a real-world study from Pakistan},
  journal = {Frontiers in Public Health},
  year = {2026},
  doi = {10.3389/fpubh.2026.1783217}
}
Kostenlos starten →